Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2022 | 05-2022 | 02-2022 | 11-2021 | 08-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,556 | 41,533 | 78,780 | 80,506 | 147,440 |
| Marketable Securities | 296,922 | 255,746 | 183,198 | 215,214 | 196,458 |
| Receivables | N/A | N/A | 6,204 | 6,204 | 204 |
| Other current assets | 0 | 0 | 2,000 | 0 | 5,000 |
| TOTAL | $354,871 | $306,789 | $280,484 | $311,118 | $358,445 |
| Non-Current Assets | |||||
| PPE Net | 16,501 | 15,507 | 13,522 | 11,340 | 9,569 |
| Investments And Advances | 69,125 | 51,538 | 123,685 | 137,189 | 121,480 |
| Other Non-Current Assets | 18,841 | 20,476 | 20,029 | 17,124 | 3,580 |
| TOTAL | $104,467 | $87,521 | $157,236 | $165,653 | $134,629 |
| Total Assets | $459,338 | $394,310 | $437,720 | $476,771 | $493,074 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,053 | 6,142 | 6,014 | 6,650 | 3,861 |
| Accrued Expenses | 19,609 | 19,734 | 11,419 | 14,549 | 11,569 |
| TOTAL | $67,500 | $72,665 | $66,049 | $66,258 | $50,680 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 36,342 | 41,319 | 43,186 | 41,212 | 35,250 |
| Other Non-Current Liabilities | 7,745 | 9,043 | 10,326 | 9,189 | 796 |
| TOTAL | $49,293 | $54,906 | $65,754 | $68,211 | $67,177 |
| Total Liabilities | $116,793 | $127,571 | $131,803 | $134,469 | $117,857 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,148 | 47,042 | 44,950 | 44,738 | 44,613 |
| Common Shares | 47 | 45 | 45 | 45 | 45 |
| Retained earnings | -354,535 | -308,826 | -263,425 | -220,892 | -183,190 |
| Other shareholders' equity | -3,742 | -3,085 | -2,066 | -608 | -59 |
| TOTAL | $342,545 | $266,739 | $305,917 | $342,302 | $375,217 |
| Total Liabilities And Equity | $459,338 | $394,310 | $437,720 | $476,771 | $493,074 |